Phase III randomized trial of surgery followed by conventional radiotherapy (5 fr/Wk) (Arm A) vs concurrent chemoradiotherapy (Arm B) vs accelerated radiotherapy (6fr/Wk) (Arm C) in locally advanced, stage III and IV, resectable, squamous cell carcinoma of oral cavity- oral cavity adjuvant therapy (OCAT): Final results (NCT00193843).
Sarbani Ghosh Laskar(Tata Memorial Hospital), Anil D′Cruz(Apollo Hospitals), Anuja Deshmukh(Tata Memorial Hospital), Tejpal Gupta(Tata Memorial Hospital), Mandar Deshpande(Tata Memorial Hospital), Jai Prakash Agarwal(Tata Memorial Hospital), Deepa Nair(Homi Bhabha National Institute), Vedang Murthy(Homi Bhabha National Institute), Pankaj Chaturvedi(Tata Memorial Hospital), Abhishek Chatterjee(Homi Bhabha National Institute), Rohini Hawaldar(Tata Memorial Hospital), Gouri Pantvaidya(Tata Memorial Hospital), Sudhir Nair(Homi Bhabha National Institute), Amit Joshi, Santam Chakraborty(Tata Medical Center), Kumar Prabhash(Homi Bhabha National Institute), Ashwini Budrukkar(Tata Memorial Hospital), Devendra Chaukar, Shilpi Sharma(Tata Memorial Hospital), Prathamesh Pai(Tata Memorial Hospital)
Cited by 21
Related Papers
AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models
|Nucleic Acids Research|2021|8.2k
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
|European Journal of Nuclear Medicine and Molecular Imaging|2011|377